Risk Factors for Persistent Chronic Cough During Consecutive Years: A Retrospective Database Analysis
The identification of patients at high risk for diseases provides clinicians essential information to better manage such patients. Persistent chronic cough (PCC) is a condition with high clinical burden and limited knowledge of the risk factors that drive the persistent symptoms. To understand the r...
Gespeichert in:
Veröffentlicht in: | The journal of allergy and clinical immunology in practice (Cambridge, MA) MA), 2022-06, Vol.10 (6), p.1587-1597 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1597 |
---|---|
container_issue | 6 |
container_start_page | 1587 |
container_title | The journal of allergy and clinical immunology in practice (Cambridge, MA) |
container_volume | 10 |
creator | Zeiger, Robert S. Schatz, Michael Zhou, Yichen Xie, Fagen Bali, Vishal Schelfhout, Jonathan Das, Amar Stern, Julie A. Chen, Wansu |
description | The identification of patients at high risk for diseases provides clinicians essential information to better manage such patients. Persistent chronic cough (PCC) is a condition with high clinical burden and limited knowledge of the risk factors that drive the persistent symptoms.
To understand the risk factors of PCC in patients with CC diagnosed by specialists.
In this retrospective study, adults aged 18 to 85 years diagnosed with CC by a pulmonologist, allergist, otolaryngologist, or gastroenterologist in the period 2011 to 2016 were identified. PCC was defined by another CC code or at least 2 cough events at least 8 weeks but no more than 4 months apart in each of the 2 consecutive years beginning 1 year after the original CC diagnosis. Unadjusted and adjusted risk ratios with 95% CI for patient characteristics at baseline in relationship to PCC were estimated by Poisson regression models with robust error variance.
Of the adults with CC, 3270 (27.4%) had PCC and 5302 (44.5%) did not have CC during follow-up; 3341 (28.1%) had CC in only 1 follow-up year and were excluded from the analysis. Compared with patients without PCC, patients with PCC were noted to have significantly increased adjusted risk ratios for the following baseline features: (1) demographic characteristics (elderly, females, and less educated); (2) comorbidities (chronic obstructive pulmonary disease, chronic sinusitis, bronchiectasis, pulmonary fibrosis, hypertension, depression, and cough complications); (3) medication dispensed (inhaled corticosteroids/long-acting beta-agonists, leukotriene modifiers, nasal corticosteroids, nasal short-acting muscarinic antagonists, proton pump inhibitors, antitussives with narcotics, and neuromodulators); and (4) specialist care, particularly with pulmonologists.
Knowledge of the independent risk factors associated with PCC should aid clinicians in identifying such patients and improve their management. |
doi_str_mv | 10.1016/j.jaip.2022.02.032 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2638723913</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2213219822002331</els_id><sourcerecordid>2638723913</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-2d2e63e0b7ef34b2c47cef6117c48fa6efc9b4e2b278fc5e7bef856a2d81a4233</originalsourceid><addsrcrecordid>eNp9kU9LAzEQxYMoKuoX8CABL15ak8l2sxUvpf4FQSl68BSy2YlmbTc12S347c1a9eDBMJBJ-M0jeY-QQ86GnPH8tB7W2i2HwACGLJWADbILwMUAgPHNn56Pix1yEGPN0iq4ZBnbJjtiBBKY5LsEZy6-0SttWh8itT7QBwzRxRablk5fg2-coVPfvbzSiy645iUdmoima90K6TPqEM_ohM6wDT4u0XxdX-hWlzoinTR6_pHU9smW1fOIB9_7Hnm6unyc3gzu7q9vp5O7gcmgaAdQAeYCWSnRiqwEk0mDNudcmqywOkdrxmWGUIIsrBmhLNEWo1xDVXCdgRB75GStuwz-vcPYqoWLBudz3aDvooJcFBLEmPfo8R-09l1I7-0pKUZyDBwSBWvKpO_FgFYtg1vo8KE4U30OqlZ9DqrPQbFUoh86-pbuygVWvyM_rifgfA1g8mLlMKhoHDYGKxeShary7j_9T3-9mRg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2673579212</pqid></control><display><type>article</type><title>Risk Factors for Persistent Chronic Cough During Consecutive Years: A Retrospective Database Analysis</title><source>Alma/SFX Local Collection</source><creator>Zeiger, Robert S. ; Schatz, Michael ; Zhou, Yichen ; Xie, Fagen ; Bali, Vishal ; Schelfhout, Jonathan ; Das, Amar ; Stern, Julie A. ; Chen, Wansu</creator><creatorcontrib>Zeiger, Robert S. ; Schatz, Michael ; Zhou, Yichen ; Xie, Fagen ; Bali, Vishal ; Schelfhout, Jonathan ; Das, Amar ; Stern, Julie A. ; Chen, Wansu</creatorcontrib><description>The identification of patients at high risk for diseases provides clinicians essential information to better manage such patients. Persistent chronic cough (PCC) is a condition with high clinical burden and limited knowledge of the risk factors that drive the persistent symptoms.
To understand the risk factors of PCC in patients with CC diagnosed by specialists.
In this retrospective study, adults aged 18 to 85 years diagnosed with CC by a pulmonologist, allergist, otolaryngologist, or gastroenterologist in the period 2011 to 2016 were identified. PCC was defined by another CC code or at least 2 cough events at least 8 weeks but no more than 4 months apart in each of the 2 consecutive years beginning 1 year after the original CC diagnosis. Unadjusted and adjusted risk ratios with 95% CI for patient characteristics at baseline in relationship to PCC were estimated by Poisson regression models with robust error variance.
Of the adults with CC, 3270 (27.4%) had PCC and 5302 (44.5%) did not have CC during follow-up; 3341 (28.1%) had CC in only 1 follow-up year and were excluded from the analysis. Compared with patients without PCC, patients with PCC were noted to have significantly increased adjusted risk ratios for the following baseline features: (1) demographic characteristics (elderly, females, and less educated); (2) comorbidities (chronic obstructive pulmonary disease, chronic sinusitis, bronchiectasis, pulmonary fibrosis, hypertension, depression, and cough complications); (3) medication dispensed (inhaled corticosteroids/long-acting beta-agonists, leukotriene modifiers, nasal corticosteroids, nasal short-acting muscarinic antagonists, proton pump inhibitors, antitussives with narcotics, and neuromodulators); and (4) specialist care, particularly with pulmonologists.
Knowledge of the independent risk factors associated with PCC should aid clinicians in identifying such patients and improve their management.</description><identifier>ISSN: 2213-2198</identifier><identifier>EISSN: 2213-2201</identifier><identifier>DOI: 10.1016/j.jaip.2022.02.032</identifier><identifier>PMID: 35272071</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acetylcholine receptors (muscarinic) ; Antagonists ; Antitussives ; Bronchiectasis ; Cardiovascular disease ; Chronic cough ; Chronic obstructive pulmonary disease ; Codes ; Comorbidities ; Comorbidity ; Corticosteroids ; Cough ; Enzymes ; Ethnicity ; Family income ; Females ; Fibrosis ; Gastroesophageal reflux ; Hypertension ; Integrated delivery systems ; Laboratories ; Lung diseases ; Narcotics ; Neuromodulation ; Obstructive lung disease ; Patients ; Persistent chronic cough ; Pharmacy ; Proton pump inhibitors ; Quality of life ; Regression analysis ; Risk factors ; Sinusitis ; Sleep</subject><ispartof>The journal of allergy and clinical immunology in practice (Cambridge, MA), 2022-06, Vol.10 (6), p.1587-1597</ispartof><rights>2022 American Academy of Allergy, Asthma & Immunology</rights><rights>Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.</rights><rights>2022. American Academy of Allergy, Asthma & Immunology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-2d2e63e0b7ef34b2c47cef6117c48fa6efc9b4e2b278fc5e7bef856a2d81a4233</citedby><cites>FETCH-LOGICAL-c428t-2d2e63e0b7ef34b2c47cef6117c48fa6efc9b4e2b278fc5e7bef856a2d81a4233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35272071$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zeiger, Robert S.</creatorcontrib><creatorcontrib>Schatz, Michael</creatorcontrib><creatorcontrib>Zhou, Yichen</creatorcontrib><creatorcontrib>Xie, Fagen</creatorcontrib><creatorcontrib>Bali, Vishal</creatorcontrib><creatorcontrib>Schelfhout, Jonathan</creatorcontrib><creatorcontrib>Das, Amar</creatorcontrib><creatorcontrib>Stern, Julie A.</creatorcontrib><creatorcontrib>Chen, Wansu</creatorcontrib><title>Risk Factors for Persistent Chronic Cough During Consecutive Years: A Retrospective Database Analysis</title><title>The journal of allergy and clinical immunology in practice (Cambridge, MA)</title><addtitle>J Allergy Clin Immunol Pract</addtitle><description>The identification of patients at high risk for diseases provides clinicians essential information to better manage such patients. Persistent chronic cough (PCC) is a condition with high clinical burden and limited knowledge of the risk factors that drive the persistent symptoms.
To understand the risk factors of PCC in patients with CC diagnosed by specialists.
In this retrospective study, adults aged 18 to 85 years diagnosed with CC by a pulmonologist, allergist, otolaryngologist, or gastroenterologist in the period 2011 to 2016 were identified. PCC was defined by another CC code or at least 2 cough events at least 8 weeks but no more than 4 months apart in each of the 2 consecutive years beginning 1 year after the original CC diagnosis. Unadjusted and adjusted risk ratios with 95% CI for patient characteristics at baseline in relationship to PCC were estimated by Poisson regression models with robust error variance.
Of the adults with CC, 3270 (27.4%) had PCC and 5302 (44.5%) did not have CC during follow-up; 3341 (28.1%) had CC in only 1 follow-up year and were excluded from the analysis. Compared with patients without PCC, patients with PCC were noted to have significantly increased adjusted risk ratios for the following baseline features: (1) demographic characteristics (elderly, females, and less educated); (2) comorbidities (chronic obstructive pulmonary disease, chronic sinusitis, bronchiectasis, pulmonary fibrosis, hypertension, depression, and cough complications); (3) medication dispensed (inhaled corticosteroids/long-acting beta-agonists, leukotriene modifiers, nasal corticosteroids, nasal short-acting muscarinic antagonists, proton pump inhibitors, antitussives with narcotics, and neuromodulators); and (4) specialist care, particularly with pulmonologists.
Knowledge of the independent risk factors associated with PCC should aid clinicians in identifying such patients and improve their management.</description><subject>Acetylcholine receptors (muscarinic)</subject><subject>Antagonists</subject><subject>Antitussives</subject><subject>Bronchiectasis</subject><subject>Cardiovascular disease</subject><subject>Chronic cough</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Codes</subject><subject>Comorbidities</subject><subject>Comorbidity</subject><subject>Corticosteroids</subject><subject>Cough</subject><subject>Enzymes</subject><subject>Ethnicity</subject><subject>Family income</subject><subject>Females</subject><subject>Fibrosis</subject><subject>Gastroesophageal reflux</subject><subject>Hypertension</subject><subject>Integrated delivery systems</subject><subject>Laboratories</subject><subject>Lung diseases</subject><subject>Narcotics</subject><subject>Neuromodulation</subject><subject>Obstructive lung disease</subject><subject>Patients</subject><subject>Persistent chronic cough</subject><subject>Pharmacy</subject><subject>Proton pump inhibitors</subject><subject>Quality of life</subject><subject>Regression analysis</subject><subject>Risk factors</subject><subject>Sinusitis</subject><subject>Sleep</subject><issn>2213-2198</issn><issn>2213-2201</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kU9LAzEQxYMoKuoX8CABL15ak8l2sxUvpf4FQSl68BSy2YlmbTc12S347c1a9eDBMJBJ-M0jeY-QQ86GnPH8tB7W2i2HwACGLJWADbILwMUAgPHNn56Pix1yEGPN0iq4ZBnbJjtiBBKY5LsEZy6-0SttWh8itT7QBwzRxRablk5fg2-coVPfvbzSiy645iUdmoima90K6TPqEM_ohM6wDT4u0XxdX-hWlzoinTR6_pHU9smW1fOIB9_7Hnm6unyc3gzu7q9vp5O7gcmgaAdQAeYCWSnRiqwEk0mDNudcmqywOkdrxmWGUIIsrBmhLNEWo1xDVXCdgRB75GStuwz-vcPYqoWLBudz3aDvooJcFBLEmPfo8R-09l1I7-0pKUZyDBwSBWvKpO_FgFYtg1vo8KE4U30OqlZ9DqrPQbFUoh86-pbuygVWvyM_rifgfA1g8mLlMKhoHDYGKxeShary7j_9T3-9mRg</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Zeiger, Robert S.</creator><creator>Schatz, Michael</creator><creator>Zhou, Yichen</creator><creator>Xie, Fagen</creator><creator>Bali, Vishal</creator><creator>Schelfhout, Jonathan</creator><creator>Das, Amar</creator><creator>Stern, Julie A.</creator><creator>Chen, Wansu</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>202206</creationdate><title>Risk Factors for Persistent Chronic Cough During Consecutive Years: A Retrospective Database Analysis</title><author>Zeiger, Robert S. ; Schatz, Michael ; Zhou, Yichen ; Xie, Fagen ; Bali, Vishal ; Schelfhout, Jonathan ; Das, Amar ; Stern, Julie A. ; Chen, Wansu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-2d2e63e0b7ef34b2c47cef6117c48fa6efc9b4e2b278fc5e7bef856a2d81a4233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acetylcholine receptors (muscarinic)</topic><topic>Antagonists</topic><topic>Antitussives</topic><topic>Bronchiectasis</topic><topic>Cardiovascular disease</topic><topic>Chronic cough</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Codes</topic><topic>Comorbidities</topic><topic>Comorbidity</topic><topic>Corticosteroids</topic><topic>Cough</topic><topic>Enzymes</topic><topic>Ethnicity</topic><topic>Family income</topic><topic>Females</topic><topic>Fibrosis</topic><topic>Gastroesophageal reflux</topic><topic>Hypertension</topic><topic>Integrated delivery systems</topic><topic>Laboratories</topic><topic>Lung diseases</topic><topic>Narcotics</topic><topic>Neuromodulation</topic><topic>Obstructive lung disease</topic><topic>Patients</topic><topic>Persistent chronic cough</topic><topic>Pharmacy</topic><topic>Proton pump inhibitors</topic><topic>Quality of life</topic><topic>Regression analysis</topic><topic>Risk factors</topic><topic>Sinusitis</topic><topic>Sleep</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zeiger, Robert S.</creatorcontrib><creatorcontrib>Schatz, Michael</creatorcontrib><creatorcontrib>Zhou, Yichen</creatorcontrib><creatorcontrib>Xie, Fagen</creatorcontrib><creatorcontrib>Bali, Vishal</creatorcontrib><creatorcontrib>Schelfhout, Jonathan</creatorcontrib><creatorcontrib>Das, Amar</creatorcontrib><creatorcontrib>Stern, Julie A.</creatorcontrib><creatorcontrib>Chen, Wansu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of allergy and clinical immunology in practice (Cambridge, MA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zeiger, Robert S.</au><au>Schatz, Michael</au><au>Zhou, Yichen</au><au>Xie, Fagen</au><au>Bali, Vishal</au><au>Schelfhout, Jonathan</au><au>Das, Amar</au><au>Stern, Julie A.</au><au>Chen, Wansu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk Factors for Persistent Chronic Cough During Consecutive Years: A Retrospective Database Analysis</atitle><jtitle>The journal of allergy and clinical immunology in practice (Cambridge, MA)</jtitle><addtitle>J Allergy Clin Immunol Pract</addtitle><date>2022-06</date><risdate>2022</risdate><volume>10</volume><issue>6</issue><spage>1587</spage><epage>1597</epage><pages>1587-1597</pages><issn>2213-2198</issn><eissn>2213-2201</eissn><abstract>The identification of patients at high risk for diseases provides clinicians essential information to better manage such patients. Persistent chronic cough (PCC) is a condition with high clinical burden and limited knowledge of the risk factors that drive the persistent symptoms.
To understand the risk factors of PCC in patients with CC diagnosed by specialists.
In this retrospective study, adults aged 18 to 85 years diagnosed with CC by a pulmonologist, allergist, otolaryngologist, or gastroenterologist in the period 2011 to 2016 were identified. PCC was defined by another CC code or at least 2 cough events at least 8 weeks but no more than 4 months apart in each of the 2 consecutive years beginning 1 year after the original CC diagnosis. Unadjusted and adjusted risk ratios with 95% CI for patient characteristics at baseline in relationship to PCC were estimated by Poisson regression models with robust error variance.
Of the adults with CC, 3270 (27.4%) had PCC and 5302 (44.5%) did not have CC during follow-up; 3341 (28.1%) had CC in only 1 follow-up year and were excluded from the analysis. Compared with patients without PCC, patients with PCC were noted to have significantly increased adjusted risk ratios for the following baseline features: (1) demographic characteristics (elderly, females, and less educated); (2) comorbidities (chronic obstructive pulmonary disease, chronic sinusitis, bronchiectasis, pulmonary fibrosis, hypertension, depression, and cough complications); (3) medication dispensed (inhaled corticosteroids/long-acting beta-agonists, leukotriene modifiers, nasal corticosteroids, nasal short-acting muscarinic antagonists, proton pump inhibitors, antitussives with narcotics, and neuromodulators); and (4) specialist care, particularly with pulmonologists.
Knowledge of the independent risk factors associated with PCC should aid clinicians in identifying such patients and improve their management.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35272071</pmid><doi>10.1016/j.jaip.2022.02.032</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2213-2198 |
ispartof | The journal of allergy and clinical immunology in practice (Cambridge, MA), 2022-06, Vol.10 (6), p.1587-1597 |
issn | 2213-2198 2213-2201 |
language | eng |
recordid | cdi_proquest_miscellaneous_2638723913 |
source | Alma/SFX Local Collection |
subjects | Acetylcholine receptors (muscarinic) Antagonists Antitussives Bronchiectasis Cardiovascular disease Chronic cough Chronic obstructive pulmonary disease Codes Comorbidities Comorbidity Corticosteroids Cough Enzymes Ethnicity Family income Females Fibrosis Gastroesophageal reflux Hypertension Integrated delivery systems Laboratories Lung diseases Narcotics Neuromodulation Obstructive lung disease Patients Persistent chronic cough Pharmacy Proton pump inhibitors Quality of life Regression analysis Risk factors Sinusitis Sleep |
title | Risk Factors for Persistent Chronic Cough During Consecutive Years: A Retrospective Database Analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T02%3A20%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20Factors%20for%20Persistent%20Chronic%20Cough%20During%20Consecutive%20Years:%20A%20Retrospective%20Database%20Analysis&rft.jtitle=The%20journal%20of%20allergy%20and%20clinical%20immunology%20in%20practice%20(Cambridge,%20MA)&rft.au=Zeiger,%20Robert%20S.&rft.date=2022-06&rft.volume=10&rft.issue=6&rft.spage=1587&rft.epage=1597&rft.pages=1587-1597&rft.issn=2213-2198&rft.eissn=2213-2201&rft_id=info:doi/10.1016/j.jaip.2022.02.032&rft_dat=%3Cproquest_cross%3E2638723913%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2673579212&rft_id=info:pmid/35272071&rft_els_id=S2213219822002331&rfr_iscdi=true |